Skip to content

Clinical trial on enzymatic agent Salizolis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32740751
Enrollment
30
Registered
2004-12-08
Start date
2004-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds Injury, Occupational Diseases, Poisoning Acute and chronic wounds

Interventions

The randomised and controlled, single blind and parallel group study will be carried out on two groups. Each group consists of 15 patients. Patients of group A are being treated according to the curre

Sponsors

JSC Biocentras (Lithuania)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with acute and chronic wounds containing necrotic tissue (thermal and chemical burns, frostbites, trophic ulcers, injuries of truncal and limb, injuries of wrist and hand, injuries of tarsus and foot, varicosis of lower limbs with ulcers and inflammation, foot ulcers, pressure sores, infections on dermal and hypodermal tissue and other purulent inflammations). Inclusion criteria: 1. Older than 18 years

Exclusion criteria

Exclusion criteria: 1. Children under the age of 18 2. Pregnant women 3. Soldiers of active service 4. Incurable patients 5. Patients with mental disorder 6. Patients dependent on drugs and alcohol 7. Subjects incapable of giving consent 8. Subjects disagree with participation in clinical trial

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Lithuania

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026